Liquidia (LQDA) Revenue (2020 - 2026)
Liquidia's (LQDA) quarterly Revenue came in at $132.9 million in Q1 2026, up 4158.49% year-on-year from $3.1 million in Q1 2025, and up 44.39% quarter-over-quarter from $92.0 million in Q4 2025.
Liquidia (LQDA) Revenue (2020 - 2026) Analysis & Trends
Liquidia's Revenue history runs 7 years deep, the most recent figure standing at $132.9 million for Q1 2026.
- On a quarterly basis, Revenue rose 4158.49% year-over-year to $132.9 million in Q1 2026; TTM through Mar 2026 was $288.1 million, a 1936.66% increase from a year earlier, with the FY2025 full-year figure at $158.3 million, up 1031.18% from the prior year.
- Revenue rose to $132.9 million in Q1 2026 per LQDA's latest filing, from $92.0 million in the prior quarter.
- Across five years, Revenue topped out at $132.9 million in Q1 2026 and bottomed at $2.9 million in Q4 2024.
- The 5-year median for Revenue is $4.4 million (2024), against an average of $19.9 million.
- Across the five-year window, Revenue sank 35.62% in 2024 and surged 4158.49% in 2026, its largest moves.
- Year by year, Revenue stood at $5.4 million in 2022, then declined by 15.47% to $4.5 million in 2023, then sank by 35.62% to $2.9 million in 2024, then jumped by 3054.65% to $92.0 million in 2025, then soared by 44.39% to $132.9 million in 2026.
- Per Business Quant, the three latest LQDA Revenue figures stand at $132.9 million (Q1 2026), $92.0 million (Q4 2025), and $54.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 781.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 132.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.87 Mn |
| Dec 31, 2025 | 92.02 Mn |
| Sep 30, 2025 | 54.34 Mn |
| Jun 30, 2025 | 8.84 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 3.66 Mn |
| Mar 31, 2024 | 2.97 Mn |
| Dec 31, 2023 | 4.53 Mn |
| Sep 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 4.79 Mn |
| Mar 31, 2023 | 4.49 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Sep 30, 2022 | 3.17 Mn |
| Jun 30, 2022 | 3.92 Mn |
| Mar 31, 2022 | 3.49 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 3.18 Mn |
| Jun 30, 2021 | 3.38 Mn |